INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS

被引：0
|
作者：
Liu, Chengfei
Zhu, Yezi
Lou, Wei
Cui, Yuanyuan
Evans, Christopher P.
Gao, Allen C.
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.289
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP24-08
引用
收藏
页码：E262 / E262
页数：1
相关论文
共 50 条
  • [41] NOVEL IMMUNOTHERAPY FOR PROSTATE CANCER COMBINING CAR T CELLS AND MYELOID CELL STAT3 INHIBITION
    Murad, John
    Priceman, Saul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A379 - A379
  • [42] MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [43] Inhibition of STAT3 Reverses the Resistance to Histone Deacetylase Inhibitors Induced By Interleukin-6 in Chronic Lymphocytic Leukemia Cells
    Lu, Kang
    Wang, Xin
    Fang, Xiaosheng
    Feng, Lili
    Chen, Na
    Li, Peipei
    Li, Xinyu
    Geng, Lingyun
    BLOOD, 2014, 124 (21)
  • [44] Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo
    Thulin, Malin Hagberg
    Maatta, Jorma
    Linder, Anna
    Sterbova, Simona
    Ohlsson, Claes
    Damber, Jan-Erik
    Widmark, Anders
    Persson, Emma
    PROSTATE, 2021, 81 (08): : 452 - 462
  • [45] Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells
    Gong, Aiyu
    He, Meilan
    Vanaja, Donkena Krishna
    Yin, Ping
    Karnes, R. Jeffrey
    Young, Charles Y. F.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (07) : 878 - 886
  • [46] Galiellalactone inhibits growth of prostate cancer cell xenografts and induces apoptosis of human prostate cancer cells expressing active Stat3
    Hellsten, R.
    Johansson, M.
    Sterner, O.
    Bjartell, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 797 - 797
  • [47] Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses
    Brown, Jennifer R.
    Walker, Sarah R.
    Heppler, Lisa N.
    Tyekucheva, Svitlana
    Nelson, Erik A.
    Klitgaard, Josephine
    Nicolais, Maria
    Kroll, Yasmin
    Xiang, Michael
    Yeh, Jennifer E.
    Chaudhury, Mousumi
    Giaccone, Zachary T.
    Fernandes, Stacey M.
    Jacobsen, Eric D.
    Fisher, David C.
    Freedman, Arnold S.
    Davids, Matthew S.
    Supko, Jeffrey G.
    Wu, Catherine
    Frank, David A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : E95 - E98
  • [48] Expression of STAT3 in Prostate Cancer Metastases
    Don-Doncow, Nicholas
    Marginean, Felicia
    Coleman, Ilsa
    Nelson, Peter S.
    Ehrnstrom, Roy
    Krzyzanowska, Agnieszka
    Morrissey, Colm
    Hellsten, Rebecka
    Bjartell, Anders
    EUROPEAN UROLOGY, 2017, 71 (03) : 313 - 316
  • [49] STAT3 activity in human prostate cancer
    Mori, Yasunori
    De Velasco, Marco A.
    Hatanaka, Yuji
    Kura, Yurie
    Sugimoto, Kouichi
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER SCIENCE, 2018, 109 : 1075 - 1075
  • [50] Targeting constitutively-activated STAT3 in hypoxic ovarian cancer
    McCann, Georgia A.
    ElNaggar, Adam
    Naidu, Shan
    Rath, Kellie S.
    Tierney, Brent J.
    Suarez, Adrian
    Cohn, David E.
    Selvendiran, Karuppaiyah
    CLINICAL CANCER RESEARCH, 2015, 21
12345